EUVIMEDEUVIMED entdecken
Crossref

Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors

Volker Morath, Corinna Brandt, Friedrich-Christian Deuschle, Claudia T Mendler, Birgit Blechert, Dominik Summer, Cyril Barinka iD, Clemens Decristoforo iD, Wolfgang A Weber, Markus Schwaiger, Arne Skerra iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.2c01066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Volker Morath und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich 81675, Germany. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Akademie Ved Cesk?? Republiky, National Institute for Cancer Research (Programme EXCELES).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesNeoplasmsMaleHumansAnimalsMiceTissue DistributionMice, SCIDPositron-Emission TomographyRadioisotopesChelating AgentsProteinsCell Line, TumorZirconiumAcetatesHeterocyclic Compounds, 1-RingFerric CompoundsHydroxamic Acids

Stichwörter der Autor:innen

GCPIIGCPIIIN-acetyl-l-aspartyl-l-glutamate dipeptidase Ifolate hydrolase 1fusarinineglutamate carboxypeptidase IIlipocalin

Substanzen

Gallium RadioisotopesRadioisotopesChelating AgentsProteinsZirconium1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononaneAcetatesHeterocyclic Compounds, 1-RingfusigenFerric Compounds

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich 81675, Germany.
  • Lehrstuhl für Biologische Chemie, School of Life Sciences, Technical University of Munich, Freising 85354, Germany.
  • Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck 6020, Austria.
  • Laboratory of Structural Biology, Institute of Biotechnology, Czech Academy of Sciences, Vestec 252 50, Czech Republic.

ORCID-Profile: Cyril Barinka, Clemens Decristoforo, Arne Skerra

Förderung

  • Deutsche Forschungsgemeinschaft
  • Akademie Ved Cesk?? Republiky
  • National Institute for Cancer Research (Programme EXCELES)

Zitieren

APA

Morath, V., Brandt, C., Deuschle, F. C., Mendler, C. T., Blechert, B., Summer, D., Barinka, C., Decristoforo, C., Weber, W. A., Schwaiger, M., & Skerra, A. (2023). Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01066

Vancouver

Morath V, Brandt C, Deuschle FC, Mendler CT, Blechert B, Summer D, et al. Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01066

BibTeX
@article{Morath2023,
  author = {Morath, Volker and Brandt, Corinna and Deuschle, Friedrich-Christian and Mendler, Claudia T and Blechert, Birgit and Summer, Dominik and Barinka, Cyril and Decristoforo, Clemens and Weber, Wolfgang A and Schwaiger, Markus and Skerra, Arne},
  title = {Molecular Design of 68 Ga- and 89 Zr-Labeled Anticalin Radioligands for PET-Imaging of PSMA-Positive Tumors},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.2c01066}
}
Kostenlos starten →